Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration via PI3K/Akt and ERK1/2 Pathways
- 521 Downloads
The objective of this study was to determine the role of Hsp90α in regulating the migration of mesenchymal stem cells (MSCs) and to investigate the underlying mechanisms of this effect. MSCs migration was assessed by wound healing assay and transwell migration assay. Hsp90α expression was silenced in MSC by siRNA (sirHsp90α). The activity of secreted metalloproteases MMP-2 and MMP-9, and their expression levels in MSC were evaluated using gelatin zymography, Western blot analysis and real-time PCR. Gene expression of VCAM-1 and CXCR4 cytokines was evaluated by real-time PCR. Akt and ERK activity were analyzed by Western blotting using antibodies against phosphorylated forms of these proteins. Treatment with Hsp90α significantly enhanced MSC migration, and this effect was blocked by transfecting MSC with sirHsp90α. Treating the cells with recombinant human Hsp90α (rhHsp90α) enhanced gene expression and protein levels of MMP-2 and MMP-9, as well as their secretion and activity. MSC incubated with rhHsp90α exhibited increased gene expression of CXCR4 and VCAM-1. Finally, the levels of phosphorylated Akt and Erk were markedly increased by rhHsp90α treatment. These findings indicate that Hsp90α promotes MSCs migration via PI3K/Akt and ERK signaling pathways, and that this effect is possibly mediated by MMPs, SDF-1/CXCR4 pathway, and VCAM-1.
KeywordsHeat shock protein Mesenchymal stem cell Migration Cytokines
This project was supported by the National Natural Science Foundation of China (Nos. 30670868, 30770887, and 30770887/H0220), the Traditional Chinese Medicine of Zhejiang Province (No. 2014ZA005), and the Zhejiang Provincial Natural Science foundation of China (Y2100362) and Science Technology Department of Zhejiang Province (2010R10G2010160). China.
- 1.Majumdar, M. K., Thiede, M. A., Haynesworth, S. E., Bruder, S. P., & Gerson, S. L. (2000). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. Journal of Hematotherapy & Stem Cell Research, 9(6), 841–848.CrossRefGoogle Scholar
- 8.Marenzi, G., & Bartorelli, A. L. (2007). Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. European Heart Journal, 28(17), 2172–2173. author reply 2173–2174.PubMedCrossRefGoogle Scholar
- 12.Yano, A., Tsutsumi, S., Soga, S., et al. (2008). Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. Proceedings of the National Academy of Sciences of the United States of America, 105(40), 15541–15546.PubMedCentralPubMedCrossRefGoogle Scholar
- 24.Lesko, E., Gozdzik, J., Kijowski, J., Jenner, B., Wiecha, O., & Majka, M. (2007). HSP90 antagonist, geldanamycin, inhibits proliferation, induces apoptosis and blocks migration of rhabdomyosarcoma cells in vitro and seeding into bone marrow in vivo. Anti-Cancer Drugs, 18(10), 1173–1181.PubMedCrossRefGoogle Scholar
- 28.Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P., & Rosen, N. (2002). Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. Journal of Biological Chemistry, 277(42), 39858–39866.PubMedCrossRefGoogle Scholar